Germany's Federal Institute for Drugs and Medical Devices May Require Bayer to Add Stronger Warnings to Yaz Label

An article on Deutsche Welle, a German news web site, the Federal Institute for Drugs and Medical Devices is looking into changing the product information for the Yasmin line of birth control pills. The changes may be made to reflect the new data coming from recent studies that show Yaz and Yasmin are twice as likely to cause blood clots - or thrombosis - than older pills. Ulrich Hagemann, head of the institute's department of drug safety said, "there is a need from my point of view to change the text" in the product information that accompanies the pills to reflect this increased risk.

A total of 130 cases of adverse drug reactions to the Yasmin line of contraceptives have been reported to Germany's Federal Institute for Drugs and Medical Devices. Felicitas Rohrer, a 25-year old German citizen, collapsed in July with three thromboses in her lung. "I got the first package in a nice little silver box with a mirror and make-up brush inside; it seemed very nice, so why shouldn't I take it? But I never heard that this pill has a much higher risk of pulmonary embolism than other pills," Felicitas Rohrer told Deutsche Welle.

The Allen Law Firm is representing women, like Felicitas, who have suffered strokes, pulmonary embolisms and deep vein thrombosis. If you or a loved one has suffered a serious injury after taking Yaz, Yasmin or Ocella, we'd love to hear from you.